These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 943598)

  • 1. [Experimental and clinical studies on pyridostigmine as an antagonist of non-depolarizing blocking agents].
    Nakao H; Fukushima K
    Masui; 1976 Feb; 25(2):136-42. PubMed ID: 943598
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyridostigmine as an antagonist of d-tubocurarine-induced and pancuronium-induced neuromuscular blockade.
    Ravin MB
    Anesth Analg; 1975; 54(3):317-21. PubMed ID: 1169015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine, and edrophonium.
    Bartkowski RR
    Anesth Analg; 1987 Jul; 66(7):594-8. PubMed ID: 3605668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of d-tubocurarine- and pancuronium-induced neuromuscular blockades by pyridostigmine in man.
    Fogdall RP; Miller RD
    Anesthesiology; 1973 Nov; 39(5):504-9. PubMed ID: 4355635
    [No Abstract]   [Full Text] [Related]  

  • 5. Intubation conditions and reversibility of a new non-depolarizing neuromuscular blocking agent, Org-NC45.
    Krieg N; Mazur L; Booij LH; Crul JF
    Acta Anaesthesiol Scand; 1980 Oct; 24(5):423-5. PubMed ID: 6110303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of Org NC 45 neuromuscular blockade by neostigmine, pyridostigmine, and 4-aminopyridine.
    Booij LH; van der Pol F; Crul JF; Miller RD
    Anesth Analg; 1980 Jan; 59(1):31-4. PubMed ID: 7188663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical evaluation of pyridostigmine bromide in the reversal of pancuronium.
    Lippmann M; Rogoff RC
    Anesth Analg; 1974; 53(1):20-3. PubMed ID: 4855709
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyridostigmin (mestinon) as an antagonist of d-tubocurarine.
    Katz RL
    Anesthesiology; 1967; 28(3):528-34. PubMed ID: 6023525
    [No Abstract]   [Full Text] [Related]  

  • 9. Neostigmine reversal of D-tubocurarine and pancuronium bromide combinations in man.
    Frankel DZ
    Can Anaesth Soc J; 1982 Jul; 29(4):395-7. PubMed ID: 7104811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical evaluation of pyridostigmin bromide in the reversal of curarization.
    Gotta AW; Sullivan CA
    Can Anaesth Soc J; 1970 Sep; 17(5):527-34. PubMed ID: 5506081
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of RX 72601 as an anti-curare agent.
    Metcalf G; Dettmar PW
    Br J Anaesth; 1975 Apr; 47(4):451-6. PubMed ID: 124579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of pyridostigmine bromide (Mestinon) as a curare-antagonist].
    Shima T; Hashimoto Y; Shiozawa S; Iwatsuki K
    Masui; 1972 May; 21(5):427-31. PubMed ID: 4263013
    [No Abstract]   [Full Text] [Related]  

  • 13. Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.
    Donati F; Ferguson A; Bevan DR
    Anesth Analg; 1983 Mar; 62(3):314-6. PubMed ID: 6299135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged response to succinylcholine following pancuronium reversal with pyridostigmine.
    Bentz EW; Stoelting RK
    Anesthesiology; 1976 Mar; 44(3):258-60. PubMed ID: 1267898
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic effects in antagonism of neuromuscular blockage: atropine-pyridostigmine versus ipratropium bromide-pyridostigmine].
    Stoyanov M; Müller H; Lobisch M; Hempelmann G
    Anaesthesist; 1984 Oct; 33(10):499-503. PubMed ID: 6239562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of neostigmine and pyridostigmine by 4-aminopyridine in the rat.
    Miller RD; Dennissen PA; van der Pol F; Agoston S; Booij LH; Crul JF
    J Pharm Pharmacol; 1978 Nov; 30(11):699-702. PubMed ID: 31433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cholinesterase activity following pancuronium and antagonism with neostigmine or pyridostigmine.
    Stoelting RK
    Anesthesiology; 1976 Dec; 45(6):674-8. PubMed ID: 984487
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular and neuromuscular effects of Org NC 45, pancuronium, metocurine, and d-tubocurarine in dogs.
    Booij LH; Edwards RP; Sohn YJ; Miller RD
    Anesth Analg; 1980 Jan; 59(1):26-30. PubMed ID: 7188662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentration of pyridostigmine during the antagonism of neuromuscular block.
    Williams NE; Calvey TN; Chan K
    Br J Anaesth; 1983 Jan; 55(1):27-31. PubMed ID: 6821619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitroglycerin and the neuromuscular blockade produced by gallamine, succinylcholine, d-tubocurarine, and pancuronium.
    Glisson SN; Sanchez MM; El-Etr AA; Lim RA
    Anesth Analg; 1980 Feb; 59(2):117-22. PubMed ID: 6768318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.